JILL BARTEK: Open Payments
NPI 1912420068 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 15 payments from 9 companies in 2025. Trend: 2023 $176 · 2024 $200 · 2025 $261
Food & beverage: $261
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Amgen Inc. | 2 | $34 |
| PFIZER INC. | 2 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Phadia US Inc. | 1 | $15 |
Products named: VRAYLAR, LEQVIO, EVENITY, NURTEC ODT, CAPLYTA, REXULTI, MOUNJARO, FANAPT.
Industry payments across MO — which companies pay providers there.
